Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASAC: Acetylsalicylic Acid as Secondary Prevention in Colorectal Cancer
NCT03326791Phase 3Completed
- Sponsor
- Oslo University Hospital
- Start
- Dec 2017
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of aspirin in Colorectal cancer with liver metastases (CRLM), sponsored by Oslo University Hospital. Started Dec 2017; status: completed.
02
Drugs
aspirin
03
Conditions
Colorectal cancer with liver metastases (CRLM)
Beyond the preview
Go deeper on NCT03326791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03326791.